Agios Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.06%131.140.0%$1315.76m
OCGNOcugen, Inc. -13.38%9.060.0%$1086.17m
NVAXNovavax, Inc. -13.01%159.7292.9%$627.38m
AMGNAmgen, Inc. -0.44%222.951.3%$546.54m
VRTXVertex Pharmaceuticals, Inc. 0.31%209.081.9%$520.46m
REGNRegeneron Pharmaceuticals, Inc. 0.72%449.952.7%$506.82m
GILDGilead Sciences, Inc. 1.60%63.761.0%$487.79m
ILMNIllumina, Inc. -3.46%402.003.5%$459.99m
ALXNAlexion Pharmaceuticals, Inc. -0.05%148.122.0%$341.36m
BIIBBiogen, Inc. -0.01%266.591.7%$320.41m
CRSPCRISPR Therapeutics AG -3.43%115.000.6%$273.24m
BNGOBionano Genomics, Inc. -19.33%6.900.0%$244.02m
EXASEXACT Sciences Corp. -3.71%121.8818.4%$227.29m
SGENSeagen Inc. -0.47%147.235.8%$208.03m
PACBPacific Biosciences of California, Inc. -6.28%29.027.2%$153.53m

Company Profile

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.